Compare · CHE vs OPCH
CHE vs OPCH
Side-by-side comparison of Chemed Corp (CHE) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.64B, about 1.8x OPCH ($3.21B).
- Over the past year, CHE is down 26.5% and OPCH is down 38.9% - CHE leads by 12.4 points.
- OPCH has been more active in the news (11 items in the past 4 weeks vs 8 for CHE).
- OPCH has more recent analyst coverage (14 ratings vs 6 for CHE).
- Company
- Chemed Corp
- Option Care Health Inc.
- Price
- $424.39-0.82%
- $20.45-3.99%
- Market cap
- $5.64B
- $3.21B
- 1M return
- +9.08%
- -26.32%
- 1Y return
- -26.48%
- -38.88%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 8
- 11
- Recent ratings
- 6
- 14
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest CHE
- Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline
- Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
- President and CEO Mcnamara Kevin J sold $842,260 worth of Capital Stock (2,000 units at $421.13), decreasing direct ownership by 2% to 90,219 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports First-Quarter 2026 Results
- Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
- SEC Form DEFR14A filed by Chemed Corp
- SEC Form DEF 14A filed by Chemed Corp
Latest OPCH
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Director Kraemer Harry M Jansen Jr bought $783,773 worth of shares (36,610 units at $21.41), increasing direct ownership by 9% to 450,000 units (SEC Form 4)
- Option Care Health Inc. filed SEC Form 8-K: Leadership Update
- Chief Financial Officer Sethna Meenal bought $327,075 worth of shares (16,225 units at $20.16), increasing direct ownership by 20% to 98,337 units (SEC Form 4)
- Chief Executive Officer Rademacher John Charles bought $264,706 worth of shares (12,500 units at $21.18), increasing direct ownership by 2% to 695,152 units (SEC Form 4)
- Option Care Health to Participate in the Bank of America Health Care Conference
- Option Care Health downgraded by BofA Securities with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits